189 related articles for article (PubMed ID: 18957623)
1. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
Wenzel RG; Tepper S; Korab WE; Freitag F
Ann Pharmacother; 2008 Nov; 42(11):1692-6. PubMed ID: 18957623
[TBL] [Abstract][Full Text] [Related]
2. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
Evans RW
MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
[TBL] [Abstract][Full Text] [Related]
3. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ
Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074
[TBL] [Abstract][Full Text] [Related]
5. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Orlova Y; Rizzoli P; Loder E
JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
[TBL] [Abstract][Full Text] [Related]
6. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome.
Sclar DA; Robison LM; Skaer TL
Headache; 2008 Jan; 48(1):126-9. PubMed ID: 18005139
[TBL] [Abstract][Full Text] [Related]
7. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
Meng Y; Yuen J
J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
[No Abstract] [Full Text] [Related]
8. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
Evans RW
Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
[No Abstract] [Full Text] [Related]
9. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
Shapiro RE; Tepper SJ
Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
Khanassov V; Hu J; Reeves D; van Marwijk H
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
Cosci F; Chouinard G; Chouinard VA; Fava GA
Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
[TBL] [Abstract][Full Text] [Related]
12. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
[No Abstract] [Full Text] [Related]
13. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits.
Molina KC; Fairman KA; Sclar DA
Drug Healthc Patient Saf; 2018; 10():37-43. PubMed ID: 29760569
[TBL] [Abstract][Full Text] [Related]
15. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
Kogut SJ
J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
[TBL] [Abstract][Full Text] [Related]
16. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
Revol R; Rault C; Polard E; Bellet F; Guy C
Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
[TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
Elli C; Novella A; Pasina L
Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391
[TBL] [Abstract][Full Text] [Related]
18. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.
Karkow DC; Kauer JF; Ernst EJ
J Clin Psychopharmacol; 2017 Oct; 37(5):518-523. PubMed ID: 28796019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
